Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer.
Tsoi DT; Inoue M; Kelly CM; Verma S; Pritchard KI; The Oncologist, 2010, vol. 15, issue 5, p 457, ISSN 1549490x. ISBN 1549490x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef